Literature DB >> 2968204

Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.

Y C Ng1, J A Schifferli, M J Walport.   

Abstract

We performed experiments to investigate whether immune complexes opsonized with C3b and iC3b transferred from CR1 on one erythrocyte to CR1 on others, and studied the effect of variation in erythrocyte CR1 number on the transfer reaction. We used populations of cells of different blood groups to study this phenomenon which were separated by differential agglutination with monoclonal anti-group antibodies. The rate of transfer of immune complexes between erythrocytes was related to CR1 concentration of both donor and recipient cells; fastest transfer occurred from donor cells of low CR1 numbers to recipient cells of high CR1. These results were not explained by a difference in the binding constant of immune complexes to erythrocytes bearing different numbers of CR1. In the absence of factor I, complexes partitioned between erythrocytes according to their relative concentrations of CR1 with no release of complexes into solution. In serum, the proportion of complexes bound to donor and recipient erythrocytes was similarly related to their respective CR1 numbers with progressive release of complexes into solution. Erythrocyte CR1 may act as a dynamic buffering system which prevents immune complexes that have bound complement from fixing to vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968204      PMCID: PMC1541672     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant.

Authors:  J Z Wimperis; M K Brenner; H G Drexler; A V Hoffbrand; H G Prentice
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Immune complex alterations occur on the human red blood cell membrane.

Authors:  M E Medof; G M Prince
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

4.  Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.

Authors:  G D Ross; J D Lambris; J A Cain; S L Newman
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.

Authors:  C Horgan; J Burge; L Crawford; R P Taylor
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.

Authors:  M E Medof; G M Prince; J J Oger
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

7.  Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.

Authors:  R G Medicus; J Melamed; M A Arnaout
Journal:  Eur J Immunol       Date:  1983-06       Impact factor: 5.532

8.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

9.  Complement receptor is an inhibitor of the complement cascade.

Authors:  K Iida; V Nussenzweig
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.

Authors:  M E Medof; K Iida; C Mold; V Nussenzweig
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  15 in total

1.  The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.

Authors:  C H Nielsen; S H Matthiesen; I Lyng; R G Leslie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.

Authors:  N Madi; J P Paccaud; G Steiger; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.

Authors:  H Satoh; E Yokota; K Tokiyama; T Kawaguchi; Y Niho
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 4.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Ligation of complement receptor 1 increases erythrocyte membrane deformability.

Authors:  Aleksandra M Glodek; Rossen Mirchev; David E Golan; Joseph A Khoory; Jennie M Burns; Sergey S Shevkoplyas; Anne Nicholson-Weller; Ionita C Ghiran
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

6.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).

Authors:  C-H Chen; I Ghiran; F J M Beurskens; G Weaver; J A Vincent; A Nicholson-Weller; L B Klickstein
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

8.  Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).

Authors:  N Madi; J P Paccaud; G Steiger; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

9.  The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Authors:  J A Schifferli; Y C Ng; J P Paccaud; M J Walport
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.